A 5-year-old girl is referred to the developmental pediatrics clinic for assessment of global developmental delay. Her mother reports she was born at term with no perinatal complications. She sat independently at 18 months, walked at 30 months, and speaks in single words only. On examination, she has microcephaly, hypertelorism, and a high-arched palate. Neuroimaging shows cortical dysplasia with polymicrogyria. Her IQ is estimated at 28. The mother denies any family history of developmental disorders. What is the most appropriate next step in management?

Explanation

## Management of Severe Intellectual Disability with Structural Brain Abnormality ### Clinical Presentation Summary **Key Point:** A child with severe intellectual disability (IQ 28, profound range: <20 would be next tier), microcephaly, hypertelorism, high-arched palate, and neuroimaging evidence of cortical dysplasia (polymicrogyria) requires urgent genetic evaluation to identify the underlying etiology. ### Why Genetic Testing is the Priority | Investigation | Rationale | Expected Yield | |---|---|---| | **Chromosomal microarray (CMA)** | Detects copy number variations (deletions/duplications) | ~15–20% in unexplained ID | | **Whole exome sequencing (WES)** | Identifies single-gene mutations causing ID and cortical dysplasia | ~30–40% in severe ID with structural brain abnormality | | **Targeted gene panels** | If specific syndrome suspected (e.g., ARX, PAFAH1B1 for lissencephaly) | High specificity if phenotype matches | **High-Yield:** Polymicrogyria is a cortical malformation associated with multiple genetic syndromes: - ARX gene mutations (X-linked lissencephaly with polymicrogyria) - PAFAH1B1 mutations (classical lissencephaly) - TUBA1A mutations (tubulinopathies) - DCDC2, ROBO1 (dyslexia-associated, but can cause ID) ### Genetic Counseling Importance **Clinical Pearl:** Identifying the genetic etiology is crucial for: 1. **Recurrence risk assessment** — if autosomal recessive, 25% recurrence; if X-linked, different risks for male/female offspring 2. **Prenatal diagnosis** — allows informed reproductive planning 3. **Targeted management** — some genetic forms have specific treatments (e.g., pyridoxine-dependent seizures, mitochondrial disorders) 4. **Prognosis** — certain genetic etiologies have better or worse outcomes ### Structured Diagnostic Algorithm ```mermaid flowchart TD A[Severe ID + Microcephaly + Cortical Dysplasia]:::outcome --> B[Obtain detailed history and neuroimaging]:::action B --> C{Structural brain abnormality confirmed?}:::decision C -->|Yes| D[Order CMA + WES]:::action D --> E[Refer to Clinical Genetics]:::action E --> F[Genetic counseling & family planning]:::action C -->|No| G[Consider metabolic screening]:::action F --> H[Identify etiology & recurrence risk]:::outcome ``` **Mnemonic: GENETIC approach to ID** — **G**enetic testing (CMA, WES), **E**tiology identification, **N**euroimaging review, **E**arly intervention planning, **T**argeted management, **I**nformed counseling, **C**ontinued monitoring [cite:Kaplan & Sadock's Synopsis of Psychiatry 12e Ch 45; American Academy of Pediatrics Clinical Report on ID Evaluation]